百科

(+)-aspicilin

(+)-aspicilin

CAS号：52461-05-9

英文名：(+)-aspicilin

分子式

C18H32O5

熔点

151 - 152 °C

密度

分子量

328.444

沸点

溶解度

信号词

危险品标志

若想填写更详细的询价信息，请点击进入询价页面

点我

基本信息

中文名称

(+)-aspicilin

英文名称

(+)-aspicilin

中文别名

英文别名

(+)-Aspicilin、(E)-(5R,6S,7R,18S)-5,6,7-Trihydroxy-18-methyl-oxacyclooctadec-3-en-2-one、(2E,4R,5S,6R,17S)-4,5,6-trihydroxyoctadeca-2-en-17-olid

CAS号

52461-05-9

分子式

C18H32O5

分子量

328.444

精确质量

328.225

PSA

86.99

LOGP

2.4716

物化性质

熔点

151 - 152 °C

合成路线

(2E,4S,5S,6R,17S)-4,5-Epoxy-6-hydroxyoctadec-2-en-17-olid

(2E,4S,5S,6R,17S)-4,5-Epoxy-6-hydroxyoctadec-2-en-17-olid

(+)-aspicilin

上游原料

共找到17个上游原料 >

ethyl (2E,4R,5S,6R,17S)-17-[[tert-butyl(diphenyl)silyl]oxy]-4,6-isopropylidenedioxy-5-[(2-methoxyethoxy)methoxy]-2-octadecenoate

ethyl (2E,4R,5S,6R,17S)-17-[[tert-butyl(diphenyl)silyl]oxy]-4,6-isopropylidenedioxy-5-[(2-methoxyethoxy)methoxy]-2-octadecenoate

(E)-(R)-4-[(4S,5R)-5-((R)-11-Acetoxy-12-bromo-dodecyl)-2,2-dimethyl-[1,3]dioxolan-4-yl]-4-(2-methoxy-ethoxymethoxy)-but-2-enoic acid ethyl ester

(E)-(R)-4-[(4S,5R)-5-((R)-11-Acetoxy-12-bromo-dodecyl)-2,2-dimethyl-[1,3]dioxolan-4-yl]-4-(2-methoxy-ethoxymethoxy)-but-2-enoic acid ethyl ester

(2R,3S,4R,15S)-15-[[tert-butyl(diphenyl)silyl]oxy]-2,4-isopropylidenedioxy-3-[(2-methoxyethoxy)methoxy]-1-hexadecanol

(2R,3S,4R,15S)-15-[[tert-butyl(diphenyl)silyl]oxy]-2,4-isopropylidenedioxy-3-[(2-methoxyethoxy)methoxy]-1-hexadecanol

(3S,4S,5R)-5-Allyl-3,4-bis-(tert-butyl-dimethyl-silanyloxy)-tetrahydro-furan-2-ol

(3S,4S,5R)-5-Allyl-3,4-bis-(tert-butyl-dimethyl-silanyloxy)-tetrahydro-furan-2-ol

(E)-(4R,5S,6R)-4,5-Bis-(tert-butyl-dimethyl-silanyloxy)-6-hydroxy-nona-2,8-dienoic acid (S)-1-methyl-dec-9-enyl ester

(E)-(4R,5S,6R)-4,5-Bis-(tert-butyl-dimethyl-silanyloxy)-6-hydroxy-nona-2,8-dienoic acid (S)-1-methyl-dec-9-enyl ester

(1R,2E,6S,17R,18S)-17-Hydroxy-6,20,20-trimethyl-5,19,21-trioxabicyclo<16.3.0>henicos-2-en-4-on

(1R,2E,6S,17R,18S)-17-Hydroxy-6,20,20-trimethyl-5,19,21-trioxabicyclo<16.3.0>henicos-2-en-4-on

上游原料

ethyl (2E,4R,5S,6R,17S)-17-[[tert-butyl(diphenyl)silyl]oxy]-4,6-isopropylidenedioxy-5-[(2-methoxyethoxy)methoxy]-2-octadecenoate (E)-(R)-4-[(4S,5R)-5-((R)-11-Acetoxy-12-bromo-dodecyl)-2,2-dimethyl-[1,3]dioxolan-4-yl]-4-(2-methoxy-ethoxymethoxy)-but-2-enoic acid ethyl ester (2R,3S,4R,15S)-15-[[tert-butyl(diphenyl)silyl]oxy]-2,4-isopropylidenedioxy-3-[(2-methoxyethoxy)methoxy]-1-hexadecanol (3S,4S,5R)-5-Allyl-3,4-bis-(tert-butyl-dimethyl-silanyloxy)-tetrahydro-furan-2-ol (E)-(4R,5S,6R)-4,5-Bis-(tert-butyl-dimethyl-silanyloxy)-6-hydroxy-nona-2,8-dienoic acid (S)-1-methyl-dec-9-enyl ester (1R,2E,6S,17R,18S)-17-Hydroxy-6,20,20-trimethyl-5,19,21-trioxabicyclo<16.3.0>henicos-2-en-4-on (2R,3S,4R)-1-Benzyloxy-2-methoxymethoxy-hept-6-ene-3,4-diol (3S,4R,5R)-5-Allyl-3,4-dihydroxy-dihydro-furan-2-one (3S,4S,5R)-5-Allyl-3,4-bis-(tert-butyl-dimethyl-silanyloxy)-dihydro-furan-2-one (4S,5R)-5-[(R)-1-(tert-Butyl-dimethyl-silanyloxy)-but-3-enyl]-2,2-dimethyl-[1,3]dioxolane-4-carboxylic acid methyl ester (E)-(R)-4-[(4S,5R)-5-((S)-11-Acetoxy-dodecyl)-2,2-dimethyl-[1,3]dioxolan-4-yl]-4-(2-methoxy-ethoxymethoxy)-but-2-enoic acid ethyl ester (2E,4R,5S,6R,17S)-17-hydroxy-4,6-isopropylidenedioxy-5-[(2-methoxyethoxy)methoxy]-2-octadecenoic acid bis-TBDMS ether of (+)-aspicilin (2E,4R,5S,6R,17S)-17-[[tert-butyl(diphenyl)silyl]oxy]-4,6-isopropylidenedioxy-5-[(2-methoxyethoxy)methoxy]-2-octadecenoic acid (2E,4S,5S,6R,17S)-4,5-Epoxy-6-hydroxyoctadec-2-en-17-olid (E)-(R)-4-((4S,5R)-5-Allyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-4-methoxymethoxy-but-2-enoic acid (S)-1-methyl-dec-9-enyl ester (4S,5R)-5-[(R)-1-(tert-Butyl-dimethyl-silanyloxy)-3-oxo-propyl]-2,2-dimethyl-[1,3]dioxolane-4-carboxylic acid methyl ester